ENDO 2023: Early Career Forum

April 04, 2022

8:00 AM-8:15 AM

Welcome and Introduction

Ursula Kaiser, MD
Professor of Medicine;
Chief, Division of Endocrinology 

Brigham and Women's Hospital
Harvard Medical School

This session will include a brief introduction and orientation to ECF programming. 

8:15 AM-8:45 AM

ENDO A to Z: How to Get the Most Learning Possible from Attending the Annual Meeting

Gary Hammer, MD, PhD
Schembechler Prof of Adrenal Cancer
University of Michigan 

This session will include clinicians, clinical scientists and basic scientists. 
This session highlights the aspects of ENDO 2023 that trainees can take advantage of during the meeting. 
After this session, attendees should be able to:

  • Identify elements of ENDO 2023 specific to trainees
  • Navigate the ENDO 2023 meeting with ease
  • Understand the organization breakdown of the meeting into basic science, clinical, and translational talks
  • Understand the value of late breaking research (oral sessions and poster sessions)
  • Use recommended resources to find topics of interest (i.e. ENDO website and phone apps)
  • Understand the goals and format of the and Meet-the-Professor sessions with an emphasis on networking opportunities.
  • Navigate the Poster Sessions with ease and use recommendations to get the most from speaking with presenters for research collaborations and networking opportunities. 
  • Point out the Professional Development Workshops which go in depth on a few topics touched upon during trainee day.



Last Updated:
Special Interest Groups

Obesity SIG

Collaborate with peers on clinical care and research related to obesity. The SIG will discuss topics such as the pharmacoeconomics of obesity, funding opportunities, how NuSH-based AOMs are changing obesity treatment, and engaging with multidisciplinary subspecialties to bridge care gaps in obesity-related comorbidities.
Special Interest Groups

Obesity SIG

Collaborate with peers on clinical care and research related to obesity. The SIG will discuss topics such as the pharmacoeconomics of obesity, funding opportunities, how NuSH-based AOMs are changing obesity treatment, and engaging with multidisciplinary subspecialties to bridge care gaps in obesity-related comorbidities.

Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.